読み込み中
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
前日終値
$7.38
+$0.06 · +0.82%
時間外
$7.42
+$0.04 · +0.54%
10月9日 19:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
日中レンジ
現在 $7.38
52週レンジ
現在 $7.38
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
87
大幅な割安
センチメント
66
強気
リスク
60
やや高いリスク
モメンタム
42
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
日中レンジ
現在 $7.38
52週レンジ
現在 $7.38
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$14.50
上昇余地（96.48%）この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI1840.1万0.00%2.3兆 USD0.03%$381.94+0.63%
Avantis U.S. Small Cap Value ETFAVUV1660.7万0.05%308.25億 USD0.25%$119.64-0.41%
iShares Russell 2000 ETFIWM1450.55万0.02%782.66億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF697.56万0.01%954億 USD0.05%$235+0.80%
State Street SPDR S&P Pharmaceuticals ETFXPH553.3万1.22%4.62億 USD0.35%$64.65+1.60%
iShares Russell 2000 Value ETFIWN498.2万0.04%138.48億 USD0.24%$210.87-0.04%
Pacer US Small Cap Cash Cows ETFCALF486.04万0.14%35.94億 USD0.59%$54.66-0.16%
Vanguard Russell 2000 ETFVTWO353.95万0.02%180億 USD0.06%$112.66+0.50%Vanguard Morningstar Total Stock Market ETFVTIAvantis U.S. Small Cap Value ETFAVUViShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFState Street SPDR S&P Pharmaceuticals ETFXPHiShares Russell 2000 Value ETFIWNPacer US Small Cap Cash Cows ETFCALFVanguard Russell 2000 ETFVTWOAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
